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Barbara L. Hempstead3 and Carlo Pincelli1
Melanoma is a highly aggressive skin tumor that originates in the epidermis from melanocytes. As melanocytes
share with the nervous system a common neuroectodermal origin and express all neurotrophins (NTs), we
evaluated the expression and function of NTs and their receptors in melanoma. We report that primary and
metastatic melanoma cell lines synthesize and secrete all NTs. Moreover, melanoma cells express the low-
affinity (p75NTR) and the high-affinity tyrosine kinase NT receptors (Trk). The inhibition of Trk receptors by
either K252a or Trk/Fc chimeras prevents proliferation, indicating that autocrine NTs are responsible for this
effect. NT-3, NT-4, and nerve growth factor (NGF) induce cell migration, with a stronger effect on metastatic cell
lines. Transfection with p75NTR small interfering RNA (p75NTRsiRNA) or treatment with K252a inhibits NT-
induced melanoma cell migration, indicating that both the low- and high-affinity NT receptors mediate this
effect. All melanoma cell lines express the p75NTR coreceptor sortilin by which proNGF stimulates migration in
melanoma cells, but not in cells transfected with p75NTRsiRNA. These results indicate that NTs, through their
receptors, play a critical role in the progression of melanoma.
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INTRODUCTION
Neurotrophins (NTs) belong to a family of structurally and
functionally related molecules that promote neuronal cell
survival and differentiation or cell death, depending on the
cell–tissue context and the receptor involved (Chao et al.,
2006). The NT family consists of four members: nerve growth
factor (NGF), brain-derived neurotrophic growth factor, NT-
3, and NT-4. NTs exert their effects by binding two classes of
transmembrane receptors, the tyrosine kinase high-affinity
receptor Trks (TrkA, TrkB, and TrkC) and the low-affinity
neurotrophin receptor (p75NTR). TrkA, TrkB, and TrkC
selectively bind NGF, brain-derived neurotrophic growth
factor, and NT-3, respectively, whereas TrkB can also bind
NT-4 (Dechant, 2001); p75NTR binds all NTs with equal low
affinity (Chao and Bothwell, 2002). NTs perform different
biological functions according to the interaction with Trk or
p75NTR (Huang and Reichardt, 2003). When NTs bind to
Trk, dimerization and autophosphorylation of the receptor
occur, promoting survival and differentiation (Segal, 2003).
On the other hand, the role of p75NTR is still controversial: in
the presence of Trk, p75NTR increases high-affinity NT
binding, thereby enhancing Trk’s ability to promote survival
(Dechant and Barde, 2002). By contrast, in the absence of
Trk, p75NTR can induce apoptosis, via its own signal
transduction, by interacting with a mounting number of
downstream molecules (Wang et al., 2001). Recently, it has
been shown that the proform of NT proNGF binds p75NTR,
in association with its coreceptor sortilin, but not Trk (Nykjaer
et al., 2004). More specifically, sortilin, a member of the vps-
10 protein family, binds the ‘‘pro’’ region of NGF, whereas
p75NTR binds mature NGF. The p75NTR–sortilin complex
couples with proNGF to induce apoptosis (Kaplan and Miller,
2004).
NTs also operate in a number of non-neuronal cells
(Kurihara et al., 2003; Rochlitzer et al., 2006). In the skin, a
complex NT network exists in which various cells are either
the target or the source of NT, thus playing autocrine and
paracrine functions (Marconi et al., 2003, 2006). In
particular, melanocytes, which share with neurons a com-
mon neuroectodermal origin, express all NTs and their
receptors, except TrkC (Pincelli and Yaar, 1997; Marconi
et al., 2006).
Melanoma, the most aggressive form of skin cancer,
originates from melanocytes. The incidence and mortality
rate of melanoma have increased at annual rates of 2–3% for
the last 30 years (Perlis and Herlyn, 2004). Although early,
thin lesions can be effectively cured by surgical excision,
advanced and metastatic melanomas are generally fatal
(Thompson and Uren, 2005). Most melanomas arise within
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the epidermis and then invade the basement membrane to
eventually disseminate to multiple organs (Balch et al., 2001).
During progression, melanoma moves from the epidermal to
the dermal microenvironment by virtue of various mechan-
isms that involve different cell types, such as keratinocytes
and fibroblasts, up- and downregulation of adhesion mole-
cule receptors, and a number of growth factors (Haass and
Herlyn, 2005). Melanoma frequently metastasizes to the
brain, this often being the initial site of melanoma metastases
(Balch et al., 2001). It has been shown that in brain-metastatic
melanoma cells, NGF promotes invasion by enhancing the
production of extracellular matrix-degradative enzymes
(Denkins et al., 2004), suggesting that NT-rich tissues such
as the brain, through a potent chemotactic activity (Nicolson
and Menter, 1995), support melanoma invasion and survival.
Yet little is known on the role of NT and their receptors in the
progression of melanoma.
We postulate that the rich NT network, which involves the
vast majority of skin cells (Jerregard et al., 2000; Marconi
et al., 2003), could play a role in melanoma development. To
verify this hypothesis, we have studied the expression and
function of NTs and their receptors in primary and metastatic
melanoma cell lines. We provide evidence that melanoma
cells express all NTs and NT receptors. Moreover, we report
that NTs modulate melanoma cell proliferation and migration
through their receptors and in association with sortilin.
RESULTS
Expression of NT in melanoma cell lines
We have recently shown that human melanocytes synthesize
and release all NTs (Marconi et al., 2006). To evaluate
whether malignant transformation affects the expression of
NTs, we analyzed NTs in melanoma cells both at the mRNA
and at the protein levels. Melanoma cells synthesize all NTs,
although at different extents, similar to normal human
melanocytes, as shown by reverse transcription-PCR
(RT-PCR) (Figure 1a). In addition, NT-3, NT-4, brain-derived
neurotrophic growth factor, and NGF proteins were detected
in the lysates of all melanoma cells. NT-3 and NT-4 levels
were at least sixfold more elevated than the other NTs in all
cell lines, with no major difference in primary (WM115,
A375) as compared to metastatic cells (Mewo, Me272,
WM266-4, and SKmel28) or normal human melanocytes
(Figure 1b). Discrepancies between mRNA and protein levels
could be explained by the difference between produced and
released protein. Alternatively, there could be some post-
transcriptional modification.
Expression of NT receptors in melanoma cell lines
As most skin cells secrete NTs (Botchkarev et al., 2006), we
were interested in evaluating whether melanoma cells could
be the target of NTs. To address this question, we investigated
the expression of NT receptors in melanoma cell lines.
Indeed, all investigated cell lines express p75NTR both at the
mRNA and at the protein levels. p75NTR mRNA and protein
were detected at various levels, but without significant
difference between primary and metastatic melanoma
(Figure 2a and b). TrkA, TrkB, and TrkC were expressed both
at the mRNA (Figure 2c, e, and g) and at the protein levels in
melanoma cells (Figure 2d, f, and h). These findings indicate
that primary and metastatic melanoma could participate in
the NT network not only by releasing NT but also by
responding to their action. Because melanoma originates
from normal melanocytes, we analyzed p75NTR and Trks in
these cells. p75NTR was expressed weakly in normal
melanocytes, and it increased after stimulation with tetra-
decanoyl phorbol acetate (TPA), a strong inducer of cell
differentiation. Even after TPA treatment, it appears that
p75NTR expression is lower than the one detected in most
melanoma cell lines (Figure 2b). Similarly, although TrkA was
expressed slightly in normal melanocytes and increased in
TPA-treated cells, its level was much higher in melanoma cell
lines (Figure 2d). TrkB was expressed more in melanoma cell
lines than in normal melanocytes, and TPA-treated cells tend
to express levels similar to those observed in A375 and
Me272 cell lines (Figure 2f). Finally, TrkC was expressed
weakly in normal melanocytes and was absent in differ-
entiated melanocytes (Figure 2h). This seems to indicate
that NT receptor expression increases during melanoma
development.
NTs modulate melanoma cell proliferation
To verify whether NTs actually exert any function on
melanoma cells, we decided to focus our attention on just
three melanoma cell lines: WM115 and WM266-4, which
are respectively the primary and metastatic melanoma
derived from the same patient and expressing high levels of
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Figure 1. NT expression in melanoma cell lines. (a) RNA was extracted from
both melanoma cell lines and normal human melanocytes. mRNA was
analyzed by RT-PCR and ethidium bromide staining. b-Actin mRNA was used
as an internal control. Control lanes (1, 2) represent amplification with no
template and RNA without reverse transcription, respectively. (b) NT protein
levels of both melanoma cells and melanocytes were evaluated by ELISA in a
conditioned medium, as described in Materials and Methods. NT protein
levels are given in pg per mg of cell lysate.
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p75NTR, and SKmel28, a metastatic melanoma cell line
expressing low levels of p75NTR. All these melanoma cells
express Trk receptors, although at different levels. We first
evaluated the curve growth of the three cell lines, under basic
conditions, up to 72 hours (Figure 3a). Cell growth curve
demonstrated that melanoma cell lines are in a proliferative
state between 24 and 72 hours after plating. Thus, successive
experiments were performed at these time points. The
addition of recombinant NGF, brain-derived neurotrophic
growth factor, NT-3, and NT-4 to the three melanoma cell
lines did not exert any significant proliferative effect
when compared to control cells at 48 hours (Figure 3b).
Because melanoma cells secrete all NTs, we examined
proliferation after blocking endogenous NTs. K252a inhibited
NT-induced Trk phosphorylation (Figure 3c) and determined
a significant reduction of melanoma cell proliferation in all
cell lines at 24 and 48 hours (Figure 3e). To evaluate the effect
of individual NTs on cell proliferation, we inhibited each
endogenous NT using recombinant human Trk/Fc chimeras,
soluble Trks, which bind NTs and prevent their interaction
with membrane receptors. TrkA/Fc, TrkB/Fc, and TrkC/Fc
chimeras inhibited NT-induced Trk phosphorylation
(Figure 3d) and significantly reduced melanoma cell prolife-
ration when compared to control (Figure 3f). These results
indicate that melanoma cells can autonomously proliferate
by releasing NTs.
NTs modulate melanoma cell migration
Melanoma is notorious for its high tendency to metastasize.
Melanoma cell migration and invasion are controlled in
various stages of tumor progression by different growth
factors and cytokines, which by autocrine and paracrine
effects enable cells to grow autonomously and confer
competence to metastasis (Lazar-Molnar et al., 2000). To
assess the role of NT on cell migration, we performed an
in vitro Boyden/Matrigel assay. NGF, NT-3, and NT-4
induced cell migration in all melanoma cell lines
(Figure 4a–c). To confirm this effect, we performed a different
migration assay (scratching assay). To rule out the possibility
that apparently migrated cells were indeed proliferating cells,
cells were pretreated with mitomycin C, a mitosis inhibitor
(Figure 4d and e). All NTs stimulated melanoma cell
migration, with a stronger effect on metastatic cell lines
(Figure 4a–e). To evaluate the role of NT receptors in
melanoma cell migration, cells were treated with p75NTR
small interfering RNA (p75NTRsiRNA). Western blotting
confirmed the knockdown of p75NTR protein (Figure 5b).
To obtain a more efficient p75NTRsiRNA transfection in
scratching experiments (chemokinesis), we plated less cells,
as compared to the previous experiment. Although mock
cells were induced to migrate by NT, p75NTRsiRNA-
transfected cells failed to respond to NT stimulation. Indeed,
the number of migrated cells treated with p75NTRsiRNA was
significantly lower than that of mock-transfected cells (Figure
5a and c). Similarly, the addition of K252a blocked
melanoma cell migration (Figure 5d and e), suggesting that
NTs stimulate melanoma cell migration and invasion via the
cooperation of the low- and high-affinity receptors.
Expression of sortilin receptor in melanoma cell lines
As sortilin acts as a coreceptor for p75NTR and binds
proNGF, independently of Trk, we evaluated the role of
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Figure 2. Expression of p75NTR and Trk receptors in melanoma cell lines. Intracellular and extracellular mRNA of (a) p75NTR, (c) TrkA, (e) TrkB, and
(g) TrkC were evaluated by RT-PCR and ethidium bromide staining. b-Actin mRNA was used as an internal control. Control lanes (1, 2) represent
amplification with no template and RNA without reverse transcription, respectively. (b) p75NTR, (d) TrkA, (f) TrkB, and (h) TrkC protein expression in
melanoma cell lines was studied by western blotting, as described in Materials and Methods. NT receptors were also evaluated in normal melanocytes
with or without the addition of TPA. b-Actin expression was used as control.
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p75NTR–sortilin complex in melanoma cells. First, we
demonstrated that all melanoma cell lines investigated in
this study express sortilin mRNA, although at different levels.
WM115 express low amounts of sortilin, both at the mRNA
and at the protein levels, as compared to the other cell lines
(Figure 6a and b). Moreover, sortilin was expressed weakly in
normal melanocytes, and it increased only after stimulation
with the TPA (Figure 6b).
Function of sortilin receptor in melanoma cell lines
As proNGF requires coexpression of sortilin and p75NTR to
induce its biological effects (Nykjaer et al., 2004), we
evaluated its functions in our melanoma cell system. TUNEL
assay showed that proNGF fails to affect survival in
melanoma cell lines. On the other hand, K252a, as expected,
induced a significant rate of apoptosis, indicating that Trk
receptors are critical for melanoma cell survival (Figure 7a).
Moreover, proNGF did not exert any effect on melanoma cell
proliferation (Figure 7b). On the other hand, proNGF induced
the migration of all melanoma cell lines, which was
statistically higher than control, as shown by Boyden/Matrigel
(Figure 7c) and wound-healing assays (Figure 7d and e). To
confirm the role of proNGF in melanoma cell migration, cells
were treated with p75NTRsiRNA. Western blotting confirmed
the knockdown of p75NTR protein (Figure 7g). Although
proNGF induced mock cells to migrate, it failed to have any
effect on p75NTRsiRNA-transfected cells (Figure 7f and h).
These findings indicate that proNGF stimulates melanoma
cell migration and invasion, possibly through the
p75NTR–sortilin complex.
DISCUSSION
Melanoma progresses along distinct phases. During the radial
growth phase, melanoma cells grow in a horizontal way
within the epidermis, whereas the vertical growth phase
involves melanoma cells that invade the dermis. We report
here that the skin NT network, which operates both in the
dermis and in the epidermis, acts on melanoma cells by
modulating proliferation and migration. First, we show that
NTs, exerting their effects on melanoma cells, are not only
derived from other skin cells, but are produced by the
melanoma itself. Indeed, the melanoma cell lines investi-
gated in this study release all NTs. On the other hand,
although there is general agreement on the expression of
p75NTR, there is still controversy on the expression of Trks in
melanoma. Previous reports based on immunohistochemical
methods have detected in melanoma TrkB, TrkC, but not
TrkA (Innominato et al., 2001). By contrast, Florenes et al.
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(2004) have recently detected phosphorylated TrkA in
melanoma cells, suggesting that this NT receptor is active
in melanoma. Consistent with this finding, we show that
melanoma cell lines express all Trk receptor mRNAs.
Moreover, western blotting confirms TrkA protein expression.
We also demonstrate the presence of p75NTR in all
melanoma cell lines, in keeping with previous works
(Herrmann et al., 1993). Taken together, these results suggest
that autocrine NTs, along with their receptors, could
contribute to melanoma progression.
To validate this premise, we have investigated the effect of
NTs on melanoma cell proliferation and migration. Exogen-
ous NTs failed to enhance melanoma cell proliferation,
possibly because of the high levels of endogenous NTs. On
the other hand, K252a and soluble Trk receptors markedly
reduced cell proliferation, indicating that endogenous NTs
are mitogenic for melanoma cells. This is, to our knowledge,
the first work on the effect of autocrine NT on melanoma cell
proliferation. Other works have investigated the role of NT
receptors on melanoma survival and brain invasiveness,
pointing to the predominant role of p75NTR (Marchetti et al.,
2004). However, these reports draw their conclusions with-
out taking into account the presence of Trks and the well-
known interactions between the high- and the low-affinity NT
receptors. The available data demonstrate that when p75NTR
signals alone, the net effect is cell death, whereas survival
signals are induced only when p75NTR complexes with Trk
(Huang and Reichardt, 2003). Therefore, considering our
finding of all Trks being expressed in melanoma cells, it is
more conceivable that NTs mediate proliferation, through the
high-affinity receptor complex Trk–p75NTR (Kuruvilla et al.,
2004).
The expression of p75NTR in melanoma has been
associated with enhanced brain metastasis, independently
of Trk. We wanted to investigate the role of NTs and their
receptors on melanoma invasiveness. Using a migration
assay, we demonstrated that all NTs stimulate melanoma cell
migration, which is significantly higher in metastatic mela-
noma than in primary melanoma cell lines. This seems to
correlate with the work of Marchetti et al. (2004), who have
emphasized the role of NT in metastatic melanoma. Indeed,
blocking p75NTR inhibits NT-induced melanoma migration,
highlighting the role of the low-affinity NT receptor.
However, our results strongly indicate that Trk receptors are
also responsible for melanoma cell migration and prolifera-
tion, as K252a and soluble Trk receptors prevent these effects,
in keeping with the expression of all Trks in melanoma.
It has been shown in neuronal cells that when p75NTR
signals independently of Trk, it requires sortilin as a
coreceptor. p75NTR–sortilin complex bound to proNGF
induces apoptosis (Nykjaer et al., 2004). In this study,
although all melanoma cells express sortilin, unexpectedly
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Figure 4. NTs modulate melanoma cell migration. (a–c) Melanoma cells plated onto 24-well Boyden/Matrigel chambers were stimulated with NT, as
described in Materials and Methods. Chemotaxis assay was performed 18 hours later. Six representative fields were counted from each migration filter,
and results are expressed as the number of migrated cells. Data are expressed as the mean±SEM of triplicate from three different experiments. *Po0.05;
**Po0.01. (d) The monolayer of melanoma cells, treated with mitomycin C, was scratched for chemokinesis assay. Cells were cultured for 48 hours
with 100 ngml1 NT, and migrated cells into the scraped area were observed. (e) In the same experiment, six areas were counted and expressed as the
mean of cell migrated per area. Data are expressed as the mean±SEM of triplicate from three different experiments. *Po0.05; **Po0.01.
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proNGF does not affect melanoma cell viability. Because
p75NTR in association with Trk plays a role in melanoma cell
migration, we investigated if p75NTR–sortilin complex,
independently of Trk, could mediate this effect. Interestingly,
proNGF strongly stimulates melanoma cell migration, sug-
gesting that p75NTR mediates melanoma invasiveness, most
likely in association with sortilin. This finding is in good
agreement with the work of Shonukan et al. (2003), who have
postulated that p75NTR mediates proNT- or NT-induced
melanoma migration by interacting with the actin-bundling
protein fascin. Although Shonukan’s paper fails to address
the role of sortilin, the notion that proNGF binds to the
p75NTR–sortilin complex only makes it very likely that
sortilin is involved in melanoma cell migration.
In conclusion, we propose that melanoma development
takes advantage of a special microenvironment provided by
the skin NT network, which also includes melanoma cells.
Indeed, melanoma cells are the target of both paracrine and
autocrine NT effects, which favor survival and invasiveness of
this tumor.
MATERIALS AND METHODS
Melanoma cell cultures
A375, Mewo, and Me272 cells were cultured in RPMI 1640
(Biochrom AG, Berlin, Germany) with 200mM L-glutamine, 1%
penicillin–streptomycin, and 10% fetal bovine serum (FBS). WM115,
WM266-4, and SKmel28 (American Type Culture Collection,
Manassas, VA) were maintained in DMEM (Biochrom AG) supple-
mented with 200mM L-glutamine, 1mM sodium pyruvate, 0.1mM
non-essential amino acids, 1% penicillin–streptomycin, and 10%
FBS. Normal human melanocytes were obtained from the foreskin
(Marconi et al., 2006) and were cultured in Medium 154 containing
FBS, basic fibroblast growth factor, transferrin, hydrocortisone,
bovine pituitary extract, heparin, insulin, penicillin, streptomycin,
and amphotericin B (Cascade Biologics, Portland, OR). Institutional
approval for experiments was not necessary.
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Figure 5. NTs modulate melanoma cell migration through Trk–p75NTR complex. (b) WM266-4 melanoma cells were transfected with 50 nM p75NTRsiRNA,
and transfection was controlled by western blotting. As a control, mock cells and cells treated with diluent alone were used. (a, c) Twenty-four hours after
transfection, the cells were scratched and treated with 100 ngml1 NT for 48 hours. Migration was calculated as follows: (c) in the same experiment, six areas
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mean±SEM of triplicate from three different experiments. **Po0.01.
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Transfection of melanoma cell line
About 70,000 cells per well were plated on six-well plates in a
penicillin/streptomycin-free melanoma medium. After 24 hours,
cells were transfected with 50 nM p75NTRsiRNA (Dharmacon Inc.,
Lafayette, CO) combined with Lipofectamin 2000 and Opti-MEM
(both from Invitrogen Corporation, Carlsbad, CA) according to the
manufacturer’s instructions. As controls, water (diluent) or water
containing Lipofectamin 2000 and Opti-MEM (mock) was used.
WM266-4 or WM115 melanoma cell lines were transfected twice
and p75NTR protein level was detected by western blotting, as
described below. For chemokinesis assay, cells were washed
24 hours after the second transfection with serum-free medium
and then treated with serum-free medium containing 100 ngml1
NT, 2.5 ngml1 proNGF, or diluent, respectively. Migration was
checked 48 hours after treatment.
ELISA
Melanoma cells were cultured in complete DMEM or RPMI 1640
culture medium, and melanocytes were cultured in complete
Medium 154. At subconfluency, fresh medium for each cell type
was substituted with the same medium containing 0.1% BSA without
FBS. After 48 hours, the conditioned medium was collected and NT
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Figure 6. Melanoma cell lines express sortilin receptor. (a) Sortilin mRNA
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assay was used to detect apoptosis. K252a-treated cells were used as positive control. (b) Melanoma cells were stimulated with 0.1 or 10 ngml1 proNGF for
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quantization was performed by a two-site enzyme immunoassay
(Quantikine; Promega, Madison, WI) according to the manufac-
turer’s instructions. The sample concentration was determined by
absorbance at 540 nm against recombinant human NT standard
protein. NT protein levels are given in pg per mg of cell lysate and
results are expressed as the mean±SEM of triplicate from three
different experiments.
RT-PCR
Total RNA was extracted from cultures using TRI Reagent method
performed as described by Sigma (Sigma-Aldrich, St Louis, MO).
One microgram of total RNA extracted was reverse transcribed and
amplified as described (Pincelli et al., 1994) with a DNA Thermal
Cycler (Perkin-Elmer, Norwalk, CT). To perform a semiquantitative
evaluation of mRNA, b-actin was used as a housekeeping gene. The
relative intensity of bands on autoradiograms was quantified by
scanning laser densitometry. The linearity of PCR was obtained by
plotting value from densitometric analysis in each band versus the
cDNA concentration. Nucleotide sequences of the oligomers used
(MWG Biotech, Ebersberg, Germany) are listed in Table S1. The PCR
was carried out at least three times for each sample. No reverse-
transcribed mRNA and buffer without template were used as
controls.
Western blot analysis
Cells were harvested on ice in p75NTR buffer (150mM NaCl, 15mM
MgCl2, 1mM EGTA, 50mM Hepes, 10% glycerol, 1% Triton X-100,
pH 7.5, and protease inhibitors 1mM phenylmethylsulfonyl fluoride,
1mgml1 aprotinin, 1mgml1 leupeptin) or Trk and sortilin buffer
(50mM Tris-HCl, 1% NP-40, 0.25% sodium deoxycholate, 150mM
NaCl, 1mM EDTA, pH 7.4, and protease inhibitors 1mM phenyl-
methylsulfonyl fluoride, 1mgml1 aprotinin, 1mgml1 leupeptin)
(Sigma-Aldrich). Western blotting was performed as previously
described (Marconi et al., 2004). Membranes were incubated
overnight at 4 1C with primary anti-human p75NTR mouse
mAb (1:1,000; Upstate, Lake Placid, NY), anti-human neurotensin
receptor 3/sortilin mouse mAb (1:250; BD Biosciences, San Jose,
CA), anti-human TrkB rabbit polyclonal antibody (1:750; Upstate),
anti-human TrkC goat polyclonal antibody (1:750; Upstate), anti-
human TrkA rabbit polyclonal antibody (1:1,000; Upstate),
and anti-human b-actin mAb (1:5,000; Sigma-Aldrich). Membranes
were then incubated for 45minutes at room temperature
with the following peroxidase-conjugated secondary antibodies:
goat anti-mouse (1:3,000; Bio-Rad, Hercules, CA) for p75NTR
and b-actin; goat anti-rabbit (1:3,000; Bio-Rad) for TrkA and TrkB;
and donkey anti-goat (1:1,000; Santa Cruz Biotechnology Inc.,
Santa Cruz, CA) for TrkC. Membranes were washed and
developed using the ECL chemiluminescent detection system
(Amersham Biosciences UK Limited, Little Chalfont, Buckingham-
shire, England).
Phosphorylation detection
A total of 500,000 melanoma cells were seeded in a p35 plate with
fresh 0.5% FBS melanoma medium for 24 hours before stimulation.
Two hours before stimulation, fresh 0.5% FBS melanoma medium
was replaced. To inhibit Trk phosphorylation, 200 nM k252a or
1mgml1 TrkA/Fc, TrkB/Fc, and TrkC/Fc were added for 1 hour, and
then the medium was replaced with fresh 0.5% FBS melanoma
medium containing 100 nM NT. After 5minutes, cell lysate was
obtained with 1 SDS sample buffer (62.5mM Tris-Hcl (pH 6.8 at
25 1C), 2% SDS, 10% glycerol, 50mM DTT, 0.01% bromophenol
blue), sonicated for 15 seconds, heated at 100 1C for 5minutes,
microcentrifuged for 5minutes, and 20 ml was loaded onto 7% SDS-
PAGE gel. Western blotting was performed as previously described.
Nitrocellulose membrane was blotted with Phospho-TrkA antibody
that recognizes all phosphorylated Trks (1:1,000; Cell Signaling
Technology, Danvers, MA). Membranes were then incubated with
the secondary goat anti-rabbit (1:3,000; Bio-Rad). Membranes were
developed using the ECL chemiluminescent detection system
(Amersham Biosciences UK Limited).
Real-time PCR
Total cellular RNA was extracted from the three melanoma cell lines
using the TRI Reagent method performed according to the
manufacturer’s instructions (Sigma-Aldrich). Quantitative real-time
PCR was performed with an ABI 7500 (Applied Biosystems, Foster
City, CA) for sortilin. As an internal control, housekeeping gene
b-actin mRNA expression was measured in a separate tube. RNAse-
free H2O was used as a negative control. A 1mg portion of RNA was
subjected to retro-transcription and amplification in a 50 ml reaction
mixture using the One-Step RT-PCR Master Mix Reagents kit
(Applied Biosystems). Both sortilin and b-actin real-time PCR
were performed using Pre-Developed TaqMan Assay Reagents
(sortilin MGB probe was FAMTM dye labeled and b-actin MGB
probe was VICTM dye labeled, Applied Biosystems). Thermal cycling
conditions for One-Step RT-PCR were as follows: initial reverse
transcription at 48 1C for 30minutes, then DNA polymerase
activation at 95 1C for 10minutes, followed by 40 cycles of
denaturation at 95 1C for 15 seconds and annealing/extension
at 60 1C for 1minute. Data from each sample were compared
with WM115 sortilin expression, as calibrators, using the
Sequence Detection Software Version 1.2.3 according to the relative
quantification (DDCt) study method (Applied Biosystems). Results
were obtained as the mean from three independent experiments.
Double-sided Student’s t-test was performed between samples and
calibrator.
MTT assay
For cell growth curve, cells were plated in a 96-well tissue culture
plate (5,000 cells per well) and MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) assay was performed at 0, 24, 48,
and 72hours after plating. For proliferation experiments, cells were
plated in a 96-well tissue culture plate and treated 24 hours after
seeding with 100 ngml1 human recombinant NT (Sigma-Aldrich) or
200 nM K252a (Merck Biosciences, Darmstadt, Germany) or
1mgml1 recombinant human TrkA/Fc, TrkB/Fc, and TrkC/Fc
chimeras (R&D Systems, Minneapolis, MN) for 48 hours. Cells were
also treated with 10 ngml1 proNGF (a kind gift from Barbara L
Hempstead, New York, NY) for 72 hours. Cell proliferation was
assessed following incubation with MTT (Sigma-Aldrich) solution at
37 1C for 4 hours. The formazan dye produced after DMSO
solubilization was evaluated by a multiwell scanning spectro-
photometer at 540 nm. The results are expressed as optical density
units or as viability percentage compared to control. Results are
calculated as the mean±SD of three different experiments. Student’s
t-test was performed for comparison of the means.
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TUNEL staining
A total of 8000 melanoma cells per well were plated onto four-well
permanox chamber slides. Twenty-four hours after seeding,
10 ngml1 proNGF or 200 nM K252a was added. Medium alone
was used as control. Ninety-six hours later, cells were fixed in
paraformaldehyde (4% in phosphate-buffered saline) and permeabi-
lized with Triton X-100 (0.1%) and sodium citrate (0.1%) at 4 1C. The
slides were stained with the In Situ Cell Death Detection kit (Roche
Diagnostics, Basel, Switzerland) as recommended by the manufac-
turer. Approximately 100 cells were evaluated in randomly selected
high-power fields, and the percentage of TUNEL-positive cells was
counted. Negative control was obtained by replacing the primary
incubation with a nucleotide mixture without TdT. Fluorescent
specimens were analyzed by confocal scanning laser microscopy
(Leica TCS4D) in conjunction with a conventional optical micro-
scope (Leica DM IRBE).
Filter assay
The migration assay was performed with a 24-well BioCoat Matrigel
Invasion Chambers migration system (BD Biosciences). A total of 105
cells per insert (8-mm pore size) were seeded and cultured for 24hours
at 37 1C. A 500ml portion of DMEM containing L-glutamine and
penicillin–streptomycin was added to the cells in the upper compart-
ment. A 600ml portion of DMEM containing L-glutamine and
penicillin–streptomycin with or without 100ngml1 NT or 2.5 ngml1
proNGF was added in the lower compartment; water was used as
control. After 18hours, cells were fixed in 95% ethanol for
30 seconds. As migrated cells move from the upper side to the lower
side of the filter, the filter was cut after fixing and cells were removed
from the upper side. Filters were washed with water, stained with
toluidine blue for 7minutes, and rinsed. Filters were placed on a glass
slide, and from each filter six fields were counted using an optical
microscope and the average of the migrated cells was calculated. The
results are calculated as the mean±SD of three different experiments.
Student’s t-test was performed for comparison of the means.
Scratching assay
A total of 50,000 cells were plated on six-well tissue culture plates and
then treated with 10mgml1 mitomycin C for 2 hours. Twenty-four
hours later, the cells were washed three times in serum-free medium
and three lines for each well were drawn along the cell monolayer
with a sterile plastic tip. Plates were washed twice with serum-free
medium to remove all detached cells and incubated in serum-free
medium with 100ngml1 NT (NGF, NT-3, or NT-4), 50 nM
p75NTRsiRNA, 200nM K252a, and 2.5 ngml1 proNGF. Water
(diluent) or water containing Lipofectamin 2000 and Opti-MEM
(mock) were used as controls. Cells were monitored at 48 and 72hours
from stimulation. The result of each experiment was expressed as the
mean of migrated cells from six different areas. The final results are
expressed as the mean±SD of three different experiments. Student’s
t-test was performed for comparison of the means.
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